[PDF] Top 20 Residual ß-cell function and microvascular complications in type 1 diabetic patients

... our patients should be ...young patients with a relatively short duration of diabetes (58% with <10 years) and conse- quently we had only 7 and 13 patients with microalbuminuria ... See full document

... endocrine and metabolic ...worldwide, and is responsible for almost 3 million deaths annually ...activities and changes in food habits among individuals resulting in increased obesity ... See full document

... 12 and 18 months, without food intake for the preceding 10 ...Evansville, IN, USA), 6 ml per kg body weight with a maximum of 360 ml) which was performed at months 0, 12 and ...18. Patients ... See full document

... microvascular complications in the eye and ...ng/mL], and less severe deficits are underrepresented. In addition, the authors high- light, as a limitation, that the results could ... See full document

... lower in T1D patients in comparison with healthy ...roles in the development of T1D versus diabetic ...higher in controls than T1D patients, our data may suggest that ... See full document

... of type 2 diabetes mellitus (DM) has been reported more frequently in patients with type 2 DM than paternal ...DM and the presence of chronic complications or metabolic syndrome ... See full document

... accumulate in the matrix lining the walls of small blood vessels in diabetic subjects Brownlee et ...results in irreversible cross-linkage of collagen containing AGE Airaksinen et ...proteins ... See full document

... outcome in trials evalu- ating the efficacy of therapies to preserve B-cell function ...SCP and IDAA1C, despite the fact that its substance did not fully predict C-peptide responses ... See full document

... Twenty-four diabetic patients were se- lected from the Outpatient Clinics of the University Hospital of the Medical School of Ribeirão Preto, USP, Ribeirão Preto, SP, Brazil (Table ...age and body ... See full document

... beta cell mass, "in vivo" or ...weaker and depend on the population ...genetic and metabolic ...IA2 and Znt8. Beta cell destruction is chronically progressive but at ... See full document

... Detection and Assessment Sys- tem (ICDAS-II) foi desenvolvido tendo por base sistemas de diagnóstico previamente aplicados, na tentativa de solu- cionar a disparidade entre os ... See full document

... worldwide. In Brazil it is present throughout the country , with different prevalence and about 2 5 million ...Genetic and immunologic characteristics of the host are chiefly responsible for ... See full document

... observed in HAM/TSP and associated systemic manifestations that have been reported from cohort ...system and neuromuscular damage may be present in conjunction in HAM/TSP, but this can ... See full document

... pain and peripheral vascular disease in diabetics and compare this with the length of time since diagnosis in type 1, and type 2 ...separating type 1 ... See full document

... and in non-DM patients with chronic kidney disease [42], but the responsible mechanisms for the dissociation between systemic and renal RAAS activity are not known ...hyperfiltration ... See full document

... cess in charge of controlling rate and ...rate in response to changes in the microenvironment. In the presence of sustained hyperglycemia, a neuropathic dysfunc- tion sets in, ... See full document

... LCFA and LCFA-carnitines. Both classes tended to be lower in the UQ than in ...decreased in concentra- tion with increasing insulin resistance and dysglycemia ...[35]. In the ... See full document

... of diabetic retinopathy had longer duration of diabetes than those without DR ...among patients with DR (28.1% vs. 59.1%, p = 0.014), and higher serum creatinine levels and higher ...those ... See full document

... before and after the surgery and follow-up ...research, and no clinical trials were to have been performed for the studies to be ...largest and smallest value and the 95% confidence ... See full document

... The patients presented inadequate meta- bolic control (defi ned as fasting glucose greater than 200 mg/dl and glycated hemoglobin greater than 11%), but did not present any in- fectious disease ... See full document